|
Minimizing in Source Fragmentation for Mass Spectrometry Based NDSRI Analytical Procedures: A Case Study of Nitroso-bumetanideー
|
|
0
|
49
|
March 15, 2026
|
|
Testing of N-nitroso-cinacalcet
|
|
8
|
964
|
March 14, 2026
|
|
Research on Nitrosamines in Complex Preparations
|
|
1
|
106
|
March 12, 2026
|
|
N-Nitroso Metamizole Impurity C
|
|
3
|
220
|
March 12, 2026
|
|
Navigating the complexities in characterization of NDSRIs using advanced analytical techniques-Pub
|
|
2
|
217
|
March 12, 2026
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
21
|
4630
|
March 7, 2026
|
|
N-Nitrosodibenzylamine infusion bags
|
|
0
|
109
|
February 27, 2026
|
|
EMA's Revision of the Acceptance Limit for N-Nitroso-N-desmethyl-diphenhydramine
|
|
1
|
262
|
February 27, 2026
|
|
NDSRI growth with respect to age
|
|
11
|
384
|
February 23, 2026
|
|
👨💻 Quantitation of N-Nitrosodimethylamine (NDMA) and N-Nitrosophenylephrine (NNPE) in Phenylephrine Hydrochloride (API) by LC-MS/MS
|
|
0
|
272
|
February 7, 2026
|
|
👨💻 N-Nitroso-Propranolol Test Method & Validation Report
|
|
0
|
131
|
February 7, 2026
|
|
👨💻 N-Nitroso-Methylphenidate Test Method and Validation Report
|
|
0
|
119
|
February 7, 2026
|
|
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity Data-Pub
|
|
1
|
209
|
February 5, 2026
|
|
Available Tools for Prediction of Potential Degradation Products from Nitrosation Reactions
|
|
4
|
245
|
February 4, 2026
|
|
N-nitroso-rivaroxaban amide
|
|
7
|
1911
|
February 4, 2026
|
|
TGA updated Established acceptable intake for nitrosamines in medicines on 29 January 2026
|
|
0
|
356
|
January 29, 2026
|
|
Nitrosamine Drug Substance-Related Impurities cause DNA methylation adducts in vitro and in primary hepatocytes upon Cytochrome P450-dependend metabolic activation-Pub
|
|
2
|
228
|
January 29, 2026
|
|
Sufentanil Nitroso impurity standard
|
|
8
|
226
|
January 29, 2026
|
|
Nitrosamine Impurities: The Analytical & Regulatory Roadmap (2024-2025)
|
|
0
|
370
|
January 20, 2026
|
|
Hunt for NDSRIs: Unveiling Hidden Threats with the Novel 15N-Enriched NAP Test-Pub
|
|
2
|
380
|
January 7, 2026
|
|
N-nitrosamides, N-nitrosoureas, Nnitrosoguanidines
|
|
7
|
507
|
December 30, 2025
|
|
Establishing Best Practice for N- Nitrosamine Read-Across and Surrogate Selection
|
|
0
|
157
|
December 22, 2025
|
|
N-Nitroso Abemaciclib
|
|
13
|
636
|
December 22, 2025
|
|
N-Nitroso vonoprazan
|
|
1
|
259
|
December 15, 2025
|
|
Nitrosamines in macrocyclic antibiotics
|
|
2
|
230
|
December 10, 2025
|
|
Issue Regarding Purchase of N-Nitroso N-Desmethyl Rosuvastatin Reference Standard
|
|
5
|
253
|
December 10, 2025
|
|
Issue with Area Drop During N-Nitroso Dorzolamide Method Setup
|
|
3
|
202
|
December 10, 2025
|
|
NDSRI in Pyrathiazine theocolate
|
|
3
|
297
|
December 5, 2025
|
|
WHO Updates on Nitrosamine Impurities
|
|
3
|
649
|
December 3, 2025
|
|
FDA Approves Reformulated Ranitidine - Nitrosamine Impurities - NDMA
|
|
3
|
466
|
November 27, 2025
|